Table 1.

Gene expression profile in ex vivo LPS-stimulated whole blood

GENE	LPS	CON-CON		AB-CON		AB-FMT		CON-FMT
CXCL9	-		1.00 ± 0.5ab		0.22 ± 0.1ab		0.08 ± 0.0a		1.52 ± 1.1b
	+		0.64 ± 0.2		0.19 ± 0.1		0.09 ± 0.0		0.32 ± 0.1
CXCL10	-		1.00 ± 0.5 c		0.16 ± 0.1ab		0.09 ± 0.0a		0.71 ± 0.4bc
	+		0.73 ± 0.4bc		0.21 ± 0.1ab		0.17 ± 0.1a		0.57 ± 0.2 c
HIF1A	-		1.00 ± 0.2		0.61 ± 0.2		0.64 ± 0.2		0.92 ± 0.2
	+		0.92 ± 0.1		0.65 ± 0.1		0.53 ± 0.1		0.89 ± 0.1
HK1	-		1.00 ± 0.2		0.69 ± 0.3		0.35 ± 0.1		0.75 ± 0.2
	+		1.56 ± 0.3 c		0.77 ± 0.2ab		0.45 ± 0.1a		1.24 ± 0.2bc
IFNG	-		1.00 ± 0.6ab		0.15 ± 0.1a		0.08 ± 0.0a		1.61 ± 0.6b
	+		1.17 ± 0.9		0.17 ± 0.1		0.04 ± 0.0		0.38 ± 0.1
IL10	-		1.00 ± 0.4ab		0.25 ± 0.2a		0.17 ± 0.1ab		0.92 ± 0.2b
	+		1.12 ± 0.3bc		0.36 ± 0.1ab		0.25 ± 0.1a		1.14 ± 0.1 c
IL12	-		1.00 ± 0.3		0.33 ± 0.2		0.47 ± 0.2		0.89 ± 0.4
	+		1.07 ± 0.3ab		0.30 ± 0.1ab		0.42 ± 0.2a		1.76 ± 0.5b
IL17	-		1.00 ± 0.4b		0.22 ± 0.1a		0.24 ± 0.1a		0.57 ± 0.3ab
	+		1.04 ± 0.4ab		0.11 ± 0.1a		0.28 ± 0.2a		1.13 ± 0.4b
PDHA1	-		1.00 ± 0.1		0.81 ± 0.2		0.82 ± 0.1		0.99 ± 0.2
	+		1.05 ± 0.2ab		0.72 ± 0.1a		0.80 ± 0.1a		1.45 ± 0.2b
PKM	-		1.00 ± 0.2		0.73 ± 0.2		0.83 ± 0.3		1.04 ± 0.3
	+		1.20 ± 0.2b		0.63 ± 0.1a		0.63 ± 0.1a		1.29 ± 0.2b
RORC	-		1.00 ± 0.2ab		0.54 ± 0.2ab		0.43 ± 0.1a		1.26 ± 0.4b
	+		1.10 ± 0.2bc		0.40 ± 0.1a		0.45 ± 0.1ab		1.61 ± 0.5 c
PPARA	-		1.00 ± 0.2b		0.75 ± 0.1ab		1.15 ± 0.2b		0.53 ± 0.1a
	+		0.79 ± 0.1		0.75 ± 0.1		0.79 ± 0.1		0.81 ± 0.1
TBX21	-		1.00 ± 0.3b		0.46 ± 0.1a		1.05 ± 0.6ab		1.03 ± 0.3ab
	+		1.45 ± 0.5bc		0.67 ± 0.1ab		0.58 ± 0.2a		1.21 ± 0.3 c
TGFB1	-		1.00 ± 0.1b		0.76 ± 0.2a		0.77 ± 0.1ab		0.76 ± 0.1ab
	+		0.83 ± 0.1ab		0.68 ± 0.1ab		0.59 ± 0.1a		1.06 ± 0.2b
TLR2	-		1.00 ± 0.3ab		0.46 ± 0.2a		0.40 ± 0.1a		1.50 ± 0.3b
	+		1.80 ± 0.3ab		0.99 ± 0.3a		0.76 ± 0.1a		2.32 ± 0.3b
TLR4	-		1.00 ± 0.3ab		0.42 ± 0.2a		0.25 ± 0.1a		1.56 ± 0.3b
	+		1.95 ± 0.4b		0.65 ± 0.2a		0.52 ± 0.2a		1.87 ± 0.1b

Target genes are ordered alphabetically according to gene name. Only genes with significant group effects are shown. Data is presented as means with standard errors. For each primer assay, the mean expression level of the control group (CON-CON) has been normalized to 1 and all values scaled accordingly. Group values in each row not sharing the same superscript letter are significantly different at a probability of 0.05 or lower.